Electronic patient-reported outcome monitoring and quality of life during later-line nivolumab therapy for advanced gastric cancer. (PubMed, Int J Clin Oncol) - Oct 23, 2026 - "Exploratory analyses suggested potential associations between specific symptomatic AEs and HRQoL deterioration during later-line nivolumab therapy for advanced gastric cancer. ePRO monitoring achieved high data completeness, although patient acceptability was limited. These findings support further evaluation of ePRO as a tool for timely symptom recognition, alongside strategies to improve acceptability."
HEOR • Journal • CNS Disorders • Dental Disorders • Depression • Gastric Cancer • Oncology • Pain • Psychiatry • Solid Tumor • Stomatitis
|
|
Hisato Kawakami; Naoki Izawa; Shunsuke Oyamada; Soichi Fumita; Takako Eguchi Nakajima; Takashi Kawaguchi; Takuhiro Yamaguchi; Tempei Miyaji; Yoshiki Horie
|